NCT06135259 2024-02-01
Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus
Ain Shams University
Phase 3 Unknown
Clinical Trials
11 trialsNCT05704894 2023-01-30
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
Blau Farmaceutica S.A.
Phase 3 Unknown
NCT00737893 2021-04-08
ERECT
Johns Hopkins University
Phase 2 Completed
NCT00254436 2018-10-25
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00017004 2017-08-09
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
GOG Foundation
Phase 3 Completed
NCT01467115 2017-05-09
DREXNECK
Drexel University
Phase 2 Completed
NCT02767765 2017-04-04
A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy
Hoffmann-La Roche
Phase 3 Completed
NCT03010579 2017-01-05
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT01048034 2013-10-29
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Nordic MDS Group
Phase 2 Completed
NCT01099202 2012-08-27
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy
M.D. Anderson Cancer Center
Phase NA Completed
NCT00348738 2007-11-02
Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome
Medical University of Vienna
Phase 3 Unknown